| Gregory Scott Engel, MD | |
|
300 State St Ste 107, Erie, PA 16507-1428 | |
| (814) 877-3900 | |
| (814) 877-3950 |
| Full Name | Gregory Scott Engel |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 38 Years |
| Location | 300 State St Ste 107, Erie, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457352841 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD039912E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Hamot Hospital | Erie, PA | Hospital |
| Upmc Northwest | Seneca, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regional Health Services Inc | 4880593722 | 484 |
News Archive
Researchers at the Joslin Diabetes Center and several other institutions have for the first time linked high levels of glutamate – a neurotransmitter in the brain produced from glucose – in people with type 1 diabetes to symptoms of depression and lower levels of cognitive performance. The findings may lead to a better understanding of the underlying mechanisms of these conditions in people with diabetes.
ACCESS PHARMACEUTICALS, INC. announced today that it initiated an internal pre-licensing program to confirm the utility of its proprietary Cobalamin (vitamin B12) platform technology for targeted delivery of siRNA therapies. The program is considered important because, despite the widely publicized potential of RNA therapy, researchers up to now have been stymied in their efforts to design a pharmaceutical product that efficiently transports siRNA therapeutics into the cells they are designed to inhibit or kill.
New research published in the British Journal of Pharmacology indicates that two currently available medications-an antifungal drug and an antidepressant-can effectively inhibit the virus that causes COVID-19 in laboratory cells.
Scientists at The Scripps Research Institute have made a breakthrough in understanding a class of cells that help wounds in skin and other epithelial tissues heal, uncovering a molecular mechanism that pushes the body into wound-repair mode.
› Verified 1 days ago
| Entity Name | Regional Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174520654 PECOS PAC ID: 4880593722 Enrollment ID: O20040108000694 |
News Archive
Researchers at the Joslin Diabetes Center and several other institutions have for the first time linked high levels of glutamate – a neurotransmitter in the brain produced from glucose – in people with type 1 diabetes to symptoms of depression and lower levels of cognitive performance. The findings may lead to a better understanding of the underlying mechanisms of these conditions in people with diabetes.
ACCESS PHARMACEUTICALS, INC. announced today that it initiated an internal pre-licensing program to confirm the utility of its proprietary Cobalamin (vitamin B12) platform technology for targeted delivery of siRNA therapies. The program is considered important because, despite the widely publicized potential of RNA therapy, researchers up to now have been stymied in their efforts to design a pharmaceutical product that efficiently transports siRNA therapeutics into the cells they are designed to inhibit or kill.
New research published in the British Journal of Pharmacology indicates that two currently available medications-an antifungal drug and an antidepressant-can effectively inhibit the virus that causes COVID-19 in laboratory cells.
Scientists at The Scripps Research Institute have made a breakthrough in understanding a class of cells that help wounds in skin and other epithelial tissues heal, uncovering a molecular mechanism that pushes the body into wound-repair mode.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory Scott Engel, MD 300 State St Ste 107, Erie, PA 16507-1428 Ph: (814) 877-3900 | Gregory Scott Engel, MD 300 State St Ste 107, Erie, PA 16507-1428 Ph: (814) 877-3900 |
News Archive
Researchers at the Joslin Diabetes Center and several other institutions have for the first time linked high levels of glutamate – a neurotransmitter in the brain produced from glucose – in people with type 1 diabetes to symptoms of depression and lower levels of cognitive performance. The findings may lead to a better understanding of the underlying mechanisms of these conditions in people with diabetes.
ACCESS PHARMACEUTICALS, INC. announced today that it initiated an internal pre-licensing program to confirm the utility of its proprietary Cobalamin (vitamin B12) platform technology for targeted delivery of siRNA therapies. The program is considered important because, despite the widely publicized potential of RNA therapy, researchers up to now have been stymied in their efforts to design a pharmaceutical product that efficiently transports siRNA therapeutics into the cells they are designed to inhibit or kill.
New research published in the British Journal of Pharmacology indicates that two currently available medications-an antifungal drug and an antidepressant-can effectively inhibit the virus that causes COVID-19 in laboratory cells.
Scientists at The Scripps Research Institute have made a breakthrough in understanding a class of cells that help wounds in skin and other epithelial tissues heal, uncovering a molecular mechanism that pushes the body into wound-repair mode.
› Verified 1 days ago
Alan N Esper, DO Surgery Medicare: Medicare Enrolled Practice Location: 5473 Village Common Dr, Suite 201, Erie, PA 16506 Phone: 814-835-9191 Fax: 814-835-3323 | |
Gregory English, Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 State St Fl 4, 4th Floor, Suite 401, Erie, PA 16507 Phone: 814-877-4577 | |
Lindsey Roach, Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 State St Fl 4, 4th Floor, Suite 401, Erie, PA 16507 Phone: 814-877-6111 | |
Jawaid Kalim, Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 State St, Suite 400a, Erie, PA 16507 Phone: 814-877-6997 | |
Brian Thomas Jones, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 145 W 23rd St Ste 101, Erie, PA 16502 Phone: 814-454-1142 Fax: 814-454-1255 | |
Dr. William Rudolph Phelps, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 101 Walten Point, Erie, PA 16511 Phone: 814-323-8630 | |
Rima Ahmad, MBBS Surgery Medicare: Accepting Medicare Assignments Practice Location: 145 W 23rd St Ste 101, Erie, PA 16502 Phone: 814-454-1142 Fax: 814-454-1255 |